Skip to main content

Table 2 Correlation coefficients between CACS and clinical variables in two statin benefit groupsa based on statin-intensity class of drug

From: Coronary artery calcium score plays an important role for cardiovascular risk stratification in the statin benefit groups of asymptomatic individuals

Total = 2886 Moderate-intensity statin therapy group
(n = 1602)
High-intensity statin therapy group
(n = 1284)
  Correlation p-value Correlation p-value
Age, year 0.202 <0.001 0.216 <0.001
Body mass index, kg/m2 0.013 0.595 0.012 0.684
Waist circumference, cm 0.026 0.299 0.041 0.151
Systolic BP, mm Hg 0.092 <0.001 0.102 <0.001
Diastolic BP, mm Hg 0.051 0.042 0.012 0.674
Heart rate, beats per minute 0.010 0.704 0.082 0.004
Total cholesterol, mg/dL 0.049 0.053 0.127 <0.001
Triglyceride, mg/dL 0.026 0.310 0.012 0.677
HDL-C, mg/dL - 0.010 0.699 - 0.006 0.835
LDL-C, mg/dL 0.061 0.016 0.144 <0.001
Fasting blood glucose, mg/dL 0.091 <0.001 0.109 <0.001
HbA1c, % 0.097 <0.001 0.179 <0.001
Fasting insulin, IU/L 0.006 <0.001 0.012 0.709
HOMA-IR, 0.033 0.224 0.034 0.281
C reactive protein, mg/dL 0.028 0.281 0.012 0.685
Ten-year ASCVDS, % 0.112 <0.001 0.254 <0.001
  1. aStatin benefit group was defined as individuals who should be considered moderate- and high-intensity statin therapy
  2. CAC coronary artery calcium, BP blood pressure, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, HOMA-IR homeostasis model assessment insulin resistance, ASCVD atherosclerotic cardiovascular disease